The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Antimicrobial Resistance (AMR) Genotyping Panels Market Between 2026 And 2030?
The market size for antimicrobial resistance (amr) genotyping panels has experienced significant growth in recent years. It is anticipated to increase from $1.45 billion in 2025 to $1.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.4%. This expansion during the preceding period can be linked to the rising occurrence of antimicrobial resistance, an increase in hospital-acquired infections, the broadening scope of molecular diagnostic capabilities, greater understanding of resistance monitoring, and the emergence of advanced genotyping technologies.
The market size for antimicrobial resistance (amr) genotyping panels is anticipated to experience swift expansion in the coming years. It is projected to achieve $2.81 billion by 2030, growing at a compound annual growth rate (CAGR) of 14.1%. This projected growth can be attributed to several factors, including increasing investments in infectious disease diagnostics, a rising demand for rapid point-of-care testing, the expansion of genomic epidemiology programs, the growing integration of amr data analytics, and an increasing regulatory focus on resistance surveillance. Significant trends expected during the forecast period involve the increasing adoption of multiplex resistance detection panels, a rising use of rapid molecular diagnostics, the growing integration of genomic surveillance tools, the expansion of hospital-based amr testing, and an enhanced focus on early resistance identification.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Drivers Are Affecting The Antimicrobial Resistance (AMR) Genotyping Panels Market Development?
The increasing occurrence of infections resistant to antimicrobials is projected to fuel the expansion of the antimicrobial resistance (AMR) genotyping panels market in the future. These infections involve diseases from microorganisms like bacteria, viruses, fungi, or parasites that have developed resistance to standard antimicrobial medications, rendering them more challenging to treat. Factors contributing to enhanced antimicrobial resistance include the excessive and improper use of antibiotics. Such practices have hastened the appearance of resistant disease-causing agents, thereby generating a need for AMR genotyping panels capable of quickly identifying resistance genes and guiding specific antimicrobial treatment. For example, data from the Centers for Disease Control and Prevention (CDC) indicates that over 2.8 million antimicrobial-resistant infections manifest annually in the US. Consequently, the growing frequency of antimicrobial-resistant infections is stimulating the development of the antimicrobial resistance (AMR) genotyping panels market.
Which Segments Define The Antimicrobial Resistance (AMR) Genotyping Panels Market Segment Structure?
The antimicrobial resistance (amr) genotyping panels market covered in this report is segmented –
1) By Product Type: Custom Panels, Pre-Designed Panels
2) By Technology: Polymerase Chain Reaction (PCR)-Based, Microarray-Based, Next-Generation Sequencing (NSG)-Based, Other Technologies
3) By Application: Clinical Diagnostics, Research, Drug Development, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-users
Subsegments:
1) By Custom Panels: Pathogen-Specific Panels, Resistance Gene-Focused Panels, Multiplex Detection Panels, Targeted Mutation Panels, Research Application Panels
2) By Pre-Designed Panels: Standardized Diagnostic Panels, Broad-Spectrum Resistance Panels, Disease-Specific Panels, Commercially Validated Panels, Ready-To-Use Screening Panels
What Trends Are Transforming The Antimicrobial Resistance (AMR) Genotyping Panels Market?
Leading companies in the antimicrobial resistance (AMR) genotyping panels market are concentrating on the development of innovative products, such as multiplex PCR-based research assays, which facilitate the concurrent detection of multiple pathogens and antibiotic resistance genes within a single test. This approach enhances research efficiency and supports quicker identification of emerging resistance patterns. Specifically, multiplex PCR-based research assays are molecular tests that amplify and detect several genetic targets simultaneously to identify pathogens and antibiotic resistance genes in a single reaction. For example, in September 2025, Molecular Designs, a US-based molecular diagnostics and research-assay company, unveiled the Urogenital Microbiota with ABX 53 Simplicity Panel, a multiplex PCR-based research assay designed to identify urinary pathogens and antibiotic resistance genes in one test. The panel allows for the simultaneous detection of 28 urogenital and urinary microbial targets (including 20 bacterial, 7 fungal, and 1 protozoan) alongside 25 antibiotic-resistance gene markers, offering same-day results and availability in both 96-well and 384-well plate formats, with the 96-well version including breakaway panels to minimize waste.
Who Are The Established Players Within The Antimicrobial Resistance (AMR) Genotyping Panels Market?
Major companies operating in the antimicrobial resistance (amr) genotyping panels market are Thermo Fisher Scientific Inc., F Hoffmann La Roche Ltd., Abbott Laboratories, Illumina Inc., bioMérieux SA., Bruker Corporation, QIAGEN NV., Cepheid Inc., Integrated DNA Technologies Inc., Seegene Inc., Oxford Nanopore Technologies plc., Streck Inc., MedGenome Inc., Vela Diagnostics Pte. Ltd., Agena Bioscience Inc., CD Genomics Inc., Curetis GmbH, T2 Biosystems Inc., 3B BlackBio Biotech India Ltd., Genefirst Ltd., OpGen Inc.
Get The Full Antimicrobial Resistance (AMR) Genotyping Panels Market Report:
Where Is The Antimicrobial Resistance (AMR) Genotyping Panels Market Primarily Concentrated By Region?
North America was the largest region in the antimicrobial resistance (AMR) genotyping panels market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance (amr) genotyping panels market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Antimicrobial Resistance (AMR) Genotyping Panels Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Antimicrobial Resistance (AMR) Genotyping Panels Market 2026, By The Business Research Company
Genotyping Assay Market Report 2026
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report
Antimicrobial Medical Device Coatings Market Report 2026
Multidrug Resistant Bacteria Market Report 2026
https://www.thebusinessresearchcompany.com/report/multidrug-resistant-bacteria-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model